Research, News & Discoveries

Apr. 1, 2021, 9:23 AM   by Bill Snyder Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus. Current vaccines and… Read More

Professor David Merryman explains how his team targeted the serotonin 2B receptor in animal models to preserve cardiac function six weeks after a heart attack. Researchers at Vanderbilt University in the US report that they have identified a protein receptor in specialised heart cells that, when removed, preserves cardiac function… Read More

by Marissa Shapiro Mar. 22, 2021, 3:45 PM Addiction expert and Assistant Professor of Pharmacology Erin Calipari will speak at the 17th annual fundraising breakfast for Mending Hearts about how the COVID-19 pandemic has affected people suffering from addiction. Erin Calipari… Read More

by Marissa Shapiro Mar. 22, 2021, 9:00 AM In recognition of Colorectal Cancer Awareness Month, the School of Medicine Basic Sciences will host a panel discussion, “On the Cutting Edge: Research Toward a Cure for Colorectal Cancer,” on Tuesday, March 30, from 11… Read More

by Marissa Shapiro Mar. 17, 2021, 9:00 AM By Miquéla Thornton Award-winning biochemist, inventor and educator Michael Marletta will speak about his nearly 50 years of studying nitric oxide—the body’s first line of defense against infection—during a seminar presented by the Vanderbilt… Read More

Mar. 15, 2021, 9:26 AM   by Leigh MacMillan Dan Roden, MD Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, received the Oscar B. Hunter Career Award in Therapeutics last week at the virtual annual meeting of the American Society… Read More

by Marissa Shapiro Mar. 10, 2021, 9:00 AM A new genome-wide CRISPR screening technique conducted by researchers at Vanderbilt University is offering new insights about how tumors in 80 to 90 percent of all cancers grow. Maria Fomicheva Ian Macara (Vanderbilt University) This novel… Read More

Mar. 4, 2021, 11:19 AM   by Bill Snyder A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine. That was one… Read More

Mar. 4, 2021, 8:54 AM   by Bill Snyder Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. This is the second monoclonal antibody against the debilitating tropical… Read More

by Ann Marie Deer Owens Mar. 2, 2021, 5:30 PM Seth Bordenstein (Vanderbilt University) Seth Bordenstein, Centennial Professor of Biological Sciences, has been elected to fellowship in the American Academy of Microbiology, the honorific leadership group within one of the… Read More